注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
NightHawk Biosciences Inc(原名:Heat Biologics Inc)是一家完全整合的生物製藥公司。該公司專門從事端到端療法的開發和商業化,這些療法使免疫系統能夠抵抗包括癌症和傳染病在內的一系列疾病。該公司通過其子公司的綜合生態系統專注於藥物開發,其中包括Skunkworx Bio(Skunkworx)、Heat Biologics(Heat)、Pelican Therapeutics(Pelican)、Scorpion Biological Service(Scorpion)和Elusys Therapeutics(Elusys)。其提供了三個技術平台,即gp96,它利用熱休克蛋白gp96的免疫刺激特性來誘導免疫系統自身對癌症和傳染病的反應;TNFRSF25靶向T細胞共刺激因子TNFRSF25以調節炎症和免疫抑制,而RapidVax旨在誘導針對新出現的生物威脅的免疫記憶並加快臨床時間。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Roger B. Cohen | - | - | Member of Scientific & Clinical Advisory Board |
John K. A. Prendergast | 70 | 2016 | Independent Lead Director |
John Monahan | 78 | 2009 | Independent Director |
Justin Stebbing | - | - | Chief Medical Advisor and Member of Scientific & Clinical Advisory Board |
Edward B. Smith | 49 | 2010 | Independent Director |
Llew Keltner | 74 | - | Member of Scientific & Clinical Advisory Board |
Gary Acton | 65 | - | Member of Scientific & Clinical Advisory Board |
Robert B. Levy | - | 2017 | Member of Scientific Advisory Board |
Anthony W. Tolcher | - | 2018 | Scientific Advisory Board Member |
Robert S. Negrin | - | 2017 | Member of Scientific Advisory Board |
Andrew C. Webber | - | 2021 | Member of Biothreat Advisory Board |
Mark Pryor | - | 2021 | Member of Biothreat Advisory Board |
David Lasseter | - | - | Member of Biothreat Advisory Board |
Greg Burel | - | 2022 | Member of Biothreat Advisory Board & Senior Advisor |
Jack Kingston | - | - | Member of Biothreat Advisory Board |
Gregory Koblentz | - | 2021 | Member of Biothreat Advisory Board |
Richard Bowman Myers | 82 | 2022 | Chairman of BioThreat Advisory Board |
Jeffrey Alan Wolf | 61 | 2008 | Founder, Chairman & CEO |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核